ProSavin®, a gene-based treatment for Parkinson’s disease, Performs Well in Parkinson’s Trial

Parkinson’s disease currently affects 4.1 million patients globally which is projected to rise to 8.7 million by 2030.  A patient with Parkinson’s disease progressively loses the ability to make the neurotransmitter dopamine, the mediator of the control of movement.  There … Continue reading

Bookmark and Share

Marijuana’s Active Ingredient May Slow Progression Of Alzheimer’s Disease

Scientists are reporting discovery in laboratory experiments of a previously unknown molecular mechanism in which the active ingredient in marijuana may slow the progression of Alzheimer’s disease (AD). Scripps Research Institute’s Kim D. Janda and colleagues used laboratory experiments to … Continue reading

Bookmark and Share

What are the 5 anti-alzheimers drugs?

What are the 5 anti-alzheimers drugs? Alzheimer’s disease, also known as presenile dementia, is a progressive form of dementia occurring in middle age, which is associated with diffuse degeneration of the brain.

Bookmark and Share